| Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials JS Andrews, U Desai, NY Kirson, ML Zichlin, DE Ball, BR Matthews Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 (1 …, 2019 | 220 | 2019 |
| Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended 4‐year follow‐up and analysis of relative progression‐free survival from the … MA Dimopoulos, S Lonial, KA Betts, C Chen, ML Zichlin, A Brun, ... Cancer 124 (20), 4032-4043, 2018 | 161 | 2018 |
| Infant malnutrition is associated with persisting attention deficits in middle adulthood JR Galler, CP Bryce, ML Zichlin, G Fitzmaurice, GD Eaglesfield, ... The Journal of nutrition 142 (4), 788-794, 2012 | 161 | 2012 |
| Impaired IQ and academic skills in adults who experienced moderate to severe infantile malnutrition: a 40-year study DP Waber, CP Bryce, JM Girard, M Zichlin, GM Fitzmaurice, JR Galler Nutritional neuroscience 17 (2), 58-64, 2014 | 110 | 2014 |
| Socioeconomic outcomes in adults malnourished in the first year of life: a 40-year study JR Galler, C Bryce, DP Waber, ML Zichlin, GM Fitzmaurice, D Eaglesfield Pediatrics 130 (1), e1-e7, 2012 | 81 | 2012 |
| Real-world survival outcomes and prognostic factors among patients receiving first targeted therapy for advanced renal cell carcinoma: a SEER–medicare database analysis SK Pal, SR Ghate, N Li, E Swallow, M Peeples, ML Zichlin, JR Perez, ... Clinical genitourinary cancer 15 (4), e573-e582, 2017 | 68 | 2017 |
| Malnutrition in the first year of life and personality at age 40 JR Galler, CP Bryce, ML Zichlin, DP Waber, N Exner, GM Fitzmaurice, ... Journal of Child Psychology and Psychiatry 54 (8), 911-919, 2013 | 59 | 2013 |
| Neuropsychological outcomes at midlife following moderate to severe malnutrition in infancy. DP Waber, CP Bryce, GM Fitzmaurice, ML Zichlin, J McGaughy, JM Girard, ... Neuropsychology 28 (4), 530, 2014 | 50 | 2014 |
| Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis D Pilon, K Joshi, JJ Sheehan, ML Zichlin, P Zuckerman, P Lefebvre, ... PLoS One 14 (10), e0223255, 2019 | 38 | 2019 |
| Clinical and economic outcomes in elderly advanced renal cell carcinoma patients starting pazopanib or sunitinib treatment: a retrospective medicare claims analysis NJ Vogelzang, SK Pal, SR Ghate, E Swallow, N Li, M Peeples, ML Zichlin, ... Advances in therapy 34, 2452-2465, 2017 | 26 | 2017 |
| Risk of thromboembolic events and associated risk factors, including treatments, in patients with immune-mediated diseases J Setyawan, F Mu, A Yarur, ML Zichlin, H Yang, C Fernan, E Billmyer, ... Clinical Therapeutics 43 (8), 1392-1407. e1, 2021 | 21 | 2021 |
| Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA SK Pal, JE Signorovitch, N Li, ML Zichlin, Z Liu, SR Ghate, JR Perez, ... International Journal of Urology 24 (4), 272-278, 2017 | 14 | 2017 |
| Drivers of excess costs of opioid abuse among a commercially insured population LM Scarpati, NY Kirson, ML Zichlin, ZB Jia, HG Birnbaum, JC Howard Am J Manag Care 23 (5), 276-282, 2017 | 11 | 2017 |
| Real-world economic outcomes during time on treatment among patients who initiated sunitinib or pazopanib as first targeted therapy for advanced renal cell carcinoma: a … NJ Vogelzang, SK Pal, SR Ghate, N Li, E Swallow, M Peeples, ML Zichlin, ... Journal of Managed Care & Specialty Pharmacy 24 (6), 525-533, 2018 | 10 | 2018 |
| Risk of thromboembolic events and associated healthcare costs in patients with inflammatory bowel disease J Setyawan, F Mu, ML Zichlin, E Billmyer, N Downes, H Yang, N Azimi, ... Advances in Therapy, 1-16, 2022 | 9 | 2022 |
| A budget impact analysis of the introduction of copanlisib for treatment of relapsed follicular lymphoma in the United States S Appukkuttan, E Duchesneau, ML Zichlin, RH Bhak, A Yaldo, M Gharibo, ... Journal of Managed Care & Specialty Pharmacy 25 (4), 437-446, 2019 | 9 | 2019 |
| Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study PF Wang, CW Yee, B Gorsh, ML Zichlin, P Paka, RH Bhak, N Boytsov, ... Leukemia & Lymphoma 64 (2), 398-406, 2023 | 8 | 2023 |
| Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and Spain P Vo, W Gao, ML Zichlin, E Fuqua, E Fadli, M Aguirre Vazquez, ... Journal of Medical Economics 22 (9), 953-959, 2019 | 7 | 2019 |
| Predictors and clinical outcomes of treatment intensification in patients with type 2 diabetes uncontrolled on basal insulin in a real-world setting L Kallenbach, AM Shui, WY Cheng, T Fan, W Hu, ML Zichlin, MS Duh, ... Endocrine Practice 24 (9), 805-814, 2018 | 7 | 2018 |
| The impact of antipsychotic dose reduction on clinical outcomes and health care resource use among medicare patients with schizophrenia ML Zichlin, F Mu, S Leo, R Ayyagari Clinical Drug Investigation 41, 853-863, 2021 | 6 | 2021 |
